Clinical trial

Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension

NCT00650338

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-03-01

PhasePHASE2

Study timeline

Study start (unknown)2008-03-01Date precision: month

Registry last updated2011-11-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Open-Angle Glaucomaunresolved

Ocular Hypertensionunresolved

Interventions

DE-104 ophthalmic solution, low concentrationDRUG

DE-104 ophthalmic solution, medium concentrationDRUG

DE-104 ophthalmic solution, high concentrationDRUG

0.005% latanoprostDRUG

Sponsors & collaborators

Santen Inc.lead sponsor

Mapped research locations

San AntonioTexas, United States3 Los AngelesCalifornia, United States1 PhiladelphiaPennsylvania, United States1 AustinTexas, United States1 OmahaNebraska, United States1 RochesterNew York, United States1 TorranceCalifornia, United States1 NorfolkVirginia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00650338 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.